More Benefits over Reduced Risks in the Long-Term Treatment with Astrazeneca Heart Drug

March 14, 2015 8:26 PM

15 0

The use of AstraZeneca’s drug Brilinta can diminish the risks of premature death, another cardiovascular disease or stroke in patients who have suffered former attacks by 16%, a long anticipated medical report revealed on Saturday.

The finding might increase sales of the blood-thinner that AstraZeneca is depending on to drive expansion, although medical professionals have to stabilize its benefits against its bleeding threats.

Read more

To category page